Menu
Back to User profile » Dr Jianhua Feng
Papers published by Dr Jianhua Feng:
Higher Red Blood Cell Distribution Width is a Poor Prognostic Factor for Patients with Chronic Myeloid Leukemia
Li T, Li X, Chen H, Huang KZ, Xie Q, Ge HY, Gao SM, Feng JH, Yang JJ, Chen ZG, Zheng XQ
Cancer Management and Research 2021, 13:1233-1243
Published Date: 10 February 2021
Normal Absolute Monocyte Count at the Time of Relapse is Associated with Improved Survival After First Salvage Therapy in Adult Patients with Early Relapsed B-Lineage Acute Lymphoblastic Leukemia
Shi Y, Wang N, Huang Z, Chen R, Huang Y, Zhu Y, Xing C, Liang B, Yu K, Feng J
Cancer Management and Research 2020, 12:7097-7105
Published Date: 10 August 2020
Idarubicin-loaded methoxy poly(ethylene glycol)-b-poly(L-lactide-co-glycolide) nanoparticles for enhancing cellular uptake and promoting antileukemia activity
Liang B, Li N, Zhang S, Qi A, Feng J, Jing W, Shi C, Ma Z, Gao S
International Journal of Nanomedicine 2019, 14:543-556
Published Date: 11 January 2019
Prognostic significance of leukopenia during the induction phase in adult B cell acute lymphoblastic leukemia
Xing C, Liang B, Wu J, Yang Q, Hu G, Yan Y, Zhang Y, Jiang S, Yu K, Feng J
Cancer Management and Research 2018, 10:625-635
Published Date: 28 March 2018
Maintenance therapy with all-trans retinoic acid and arsenic trioxide improves relapse-free survival in adults with low- to intermediate-risk acute promyelocytic leukemia who have achieved complete remission after consolidation therapy
Liang B, Zheng ZY, Shi YF, Chen JJ, Hu XD, Qian HL, Shen ZJ, Jiang SF, Yu K, Feng JH
OncoTargets and Therapy 2017, 10:2305-2313
Published Date: 26 April 2017